DK331287D0 - Praeparater til hindring af transplantationsudstoedelse - Google Patents

Praeparater til hindring af transplantationsudstoedelse

Info

Publication number
DK331287D0
DK331287D0 DK331287A DK331287A DK331287D0 DK 331287 D0 DK331287 D0 DK 331287D0 DK 331287 A DK331287 A DK 331287A DK 331287 A DK331287 A DK 331287A DK 331287 D0 DK331287 D0 DK 331287D0
Authority
DK
Denmark
Prior art keywords
heparin
preparations
humans
preventing transplant
per cent
Prior art date
Application number
DK331287A
Other languages
English (en)
Other versions
DK331287A (da
DK169422B1 (da
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Yeda Res & Dev
Hadassah Mid Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Hadassah Mid Org filed Critical Yeda Res & Dev
Publication of DK331287D0 publication Critical patent/DK331287D0/da
Publication of DK331287A publication Critical patent/DK331287A/da
Application granted granted Critical
Publication of DK169422B1 publication Critical patent/DK169422B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK331287A 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse DK169422B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection
IL7925486 1986-06-26

Publications (3)

Publication Number Publication Date
DK331287D0 true DK331287D0 (da) 1987-06-26
DK331287A DK331287A (da) 1987-12-27
DK169422B1 DK169422B1 (da) 1994-10-31

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331287A DK169422B1 (da) 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse

Country Status (10)

Country Link
EP (1) EP0251134B1 (da)
JP (1) JP2527749B2 (da)
AT (1) ATE82502T1 (da)
AU (1) AU608228B2 (da)
DE (1) DE3782686T2 (da)
DK (1) DK169422B1 (da)
ES (1) ES2052514T3 (da)
GR (1) GR3006814T3 (da)
IL (1) IL79254A0 (da)
NO (1) NO872675L (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
ATE330620T1 (de) 1997-07-14 2006-07-15 Takashi Muramatsu Verwendung von midkin oder von anti-midkin antikörper
WO2003022291A1 (en) 2001-09-12 2003-03-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
AU2001234730A1 (en) 2000-02-01 2001-08-14 Beth Israel Deaconess Medical Center Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
EP1748781B1 (en) 2004-05-27 2012-12-19 Baxter International Inc. Methods for treating bleeding disorders using sulfated polysaccharides
EP2326334A2 (en) 2008-08-22 2011-06-01 Baxter Healthcare SA Methods for treating bleeding disorders
JP6393453B2 (ja) 2010-01-14 2018-09-19 バクスアルタ ゲーエムベーハー 出血性障害を治療するための方法及び組成物
DK2734213T3 (da) 2011-07-19 2018-08-13 Baxalta GmbH Resorptionsfremmere som additiver til at forbedre den orale formulering af ikke-antikoagulerende sulfatholdige polysaccharider
ES2737025T3 (es) 2012-08-14 2020-01-09 Baxalta GmbH Métodos y sistemas para el cribado de composiciones que comprenden polisacáridos sulfados no anticoagulantes
WO2014158321A1 (en) 2013-03-12 2014-10-02 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
ES2774102T3 (es) * 2015-06-11 2020-07-16 Univ Maastricht Procedimiento de prevención de fallos de trasplante en un huésped

Also Published As

Publication number Publication date
EP0251134A3 (en) 1989-05-03
NO872675D0 (no) 1987-06-25
EP0251134B1 (en) 1992-11-19
IL79254A0 (en) 1986-09-30
DE3782686D1 (de) 1992-12-24
GR3006814T3 (da) 1993-06-30
NO872675L (no) 1987-12-28
AU7470687A (en) 1988-01-07
ATE82502T1 (de) 1992-12-15
AU608228B2 (en) 1991-03-28
ES2052514T3 (es) 1994-07-16
JP2527749B2 (ja) 1996-08-28
DE3782686T2 (de) 1993-06-09
DK331287A (da) 1987-12-27
EP0251134A2 (en) 1988-01-07
DK169422B1 (da) 1994-10-31
JPS6388127A (ja) 1988-04-19

Similar Documents

Publication Publication Date Title
DK331287A (da) Praeparater til hindring af transplantationsudstoedelse
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
EP0184040A3 (en) Method and system for removing immunosuppressive components from the blood of mammals
BG100474A (bg) О-арил, о-алкил, о-алкенил и о-алкинил-макролидис имуносупресивно действие
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
OA07116A (fr) Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
DE68913075D1 (de) Stabilisiertes Arzneimittel und Verfahren zu dessen Herstellung.
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
ES2001707A6 (es) Un procedimiento para preparar una sustancia anticoagulante de placenta humana
EP0011651A4 (en) Pharmaceutical preparation containing 3-oxo-2,3-dihydro (1) -benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of caridovascular disorders.
DK0506658T3 (da) Sammensætninger og fremgangsmåde til behandling af smertefulde, inflammatoriske eller allergiske lidelser
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE170399T1 (de) Zusammensetzung und verfahren zur behandlung viraler infektionen
EP0058397A3 (en) Anticoagulant and the use thereof
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
ES2032192T3 (es) Composiciones elastomeras reticulables.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.
WO1992004359A3 (en) Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.

Legal Events

Date Code Title Description
A0 Application filed
B1 Patent granted (law 1993)
PBP Patent lapsed